Scientists identify how children develop immunity to bacterial infection, paving way for vaccine
bacterial infection
Strep A, a breakthrough that could speed up
vaccine development
and save up to half a million lives each year, a new study has said.
Strep A, or
Group A Streptococcus
, is a common bacterium that can cause mild conditions such as sore throat and skin infections, but in severe cases leads to life-threatening illnesses.
Thousands of people in low and middle-income countries die each year after contracting the infection, however, deaths from Strep A are relatively uncommon in more affluent nations by comparison. A deadly Strep A outbreak in the UK and Europe in late 2022 resulted in hundreds of deaths, including of many children.
Working in partnership with the
Medical Research Council
(MRC) Unit The Gambia at London School of Hygiene and Tropical Medicine, the University of Sheffield research team tracked how children in The Gambia develop natural immunity to Strep A.
They were able to identify the specific antibodies that are linked to protection from the potentially fatal infection, according to the study published in Nature Medicine, a monthly medical journal.
The researchers looked at how antibodies - our natural defence against infection - develop in people in The Gambia from birth and throughout their lives. It found that infants are born with some maternal protection against Strep A, but that quickly fades away. Young children rapidly develop antibody responses to various parts of the bacteria after exposure to Strep A. "Identifying this key window for developing immunity is a critical discovery for future vaccine strategies," the study said.
Lead author Dr Alex Keeley, a Wellcome Clinical PhD Fellow in
Global Health
at the MRC Unit the Gambia and the University of Sheffield's Florey Institute of Infection, said understanding this process removes a major obstacle to vaccine development. "For the first time in humans, we have observed how antibodies formed after vaccination could work to prevent infections," he said.
Gambian scientist Fatouamta Camara, who was part of the research, said Strep A has a "devastating burden" on communities, both in health and socio-economic impact. "A vaccine offers hope to break this cycle and allow children to thrive," she said.
The study was part of a collaboration between Sheffield's Florey Institute of Infection and the GSK Vaccine Institute for Global Health.
Professor Thushan de Silva, Co-Director of the Florey Institute of Infection in Sheffield and a Principal Investigator at the MRC Unit The Gambia, who supervised the research, said: "This study reflects the value of working across institutions to deliver high-quality, impactful research in global health."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
2 days ago
- Hindustan Times
Month-old baby's death in Gambia raises concern over female genital mutilation
Rights activists in The Gambia are calling for justice after a one-month-old baby's death was linked to female genital mutilation, a widely practised but illegal procedure up for review before the country's Supreme Court. The death has sparked outrage among women's rights defenders working to combat the deeply rooted cultural and religious practice that they say is a harmful violation against women and girls.(X/@AmnestyWARO) The Gambia has one of the highest rates of FGM in the world, with 73 percent of women and girls aged 15 to 49 having undergone the procedure, according to 2024 figures from UNICEF. The baby girl was pronounced dead upon arrival at a hospital in the capital Banjul after being "allegedly subjected to circumcision" and developing severe bleeding, The Gambia Police Force said in a statement Sunday. The death has sparked outrage among women's rights defenders working to combat the deeply rooted cultural and religious practice that they say is a harmful violation against women and girls. "FGM is not a cultural tradition to be defended -- it is a form of gender-based violence that can kill," Santana Simiyu, a human rights lawyer with rights group Equality Now, said in a statement sent to AFP Tuesday. Two women allegedly involved in the case are in custody, police said, as an investigation is carried out in the western town of Wellingara, where the incident occurred. Researchers at Britain's University of Birmingham estimated in a study published in 2023 that approximately 44,320 girls and young women die each year due to FGM in the countries where it is practised. Former Gambian dictator Yahya Jammeh, now in exile, outlawed FGM in 2015, branding it outdated and not a requirement of Islam. Parliament later that year adopted the first law specifically banning the practice, which is now punishable by up to three years in prison but is rarely enforced. In July 2024, lawmakers revisited the matter, upholding the 2015 law despite pressure from religious traditionalists. But the ban was immediately challenged before the Gambian Supreme Court, where the petition remains pending. "If the Gambia's Supreme Court rules that the country's law prohibiting FGM is unconstitutional, it would have a hugely detrimental impact on the well-being of women and girls, leaving them without legal protections," Simiyu said. FGM involves the partial or total removal of the female external genitalia or other injuries to the female genital organs. It can lead to serious health problems including infections, bleeding, infertility and complications in childbirth.
Indian Express
2 days ago
- Indian Express
‘Violence, pure and simple': Two arrested after baby dies from suspected female genital mutilation in Gambia
Two women have been arrested in Gambia over the death of a one-month-old baby girl who was subjected to female genital mutilation (FGM), the BBC reported. Police said the infant was taken to a hospital in the capital, Banjul, after developing severe bleeding, but was pronounced dead on arrival. An autopsy is being conducted to determine the cause of death, but BBC reports that many have linked it to FGM, a practice outlawed in the West African nation since 2015. 'Culture is no excuse, tradition is no shield, this is violence, pure and simple,' a non-governmental organisation, Women In Leadership and Liberation (WILL), said in a statement. The organisation's founder, Fatou Baldeh, told the BBC that more babies were undergoing the procedure as parents believed they healed faster and, because of the law, it was easier to disguise when performed at a young age. MP Abdoulie Ceesay, who represents the Kombo North District where the incident occurred, said: 'The loss of this innocent child must not be forgotten. Let it mark a turning point and a moment for our nation to renew its unwavering commitment to protecting every child's right to life, safety, and dignity.' FGM includes procedures that involve altering or injuring the female genitalia for non-medical or cultural reasons, and is recognised internationally as a violation of human rights and the health of girls and women. WHO classifies four types of FGM- Gambia is among 10 countries with the highest rates of FGM, with 73 per cent of women and girls aged 15 to 49 having undergone the procedure, many before the age of six, according to the BBC. Under Gambian law, those found guilty of performing FGM face fines and prison terms of up to three years, or life sentences if a girl dies as a result.
The Hindu
4 days ago
- The Hindu
Scientists identify how children develop immunity to bacterial infection, paving way for vaccine
Scientists have discovered how young children naturally develop immunity to bacterial infection Strep A, a breakthrough that could speed up vaccine development and save up to half a million lives each year, a new study has said. Tracking Strep A immunity Strep A, or Group A Streptococcus, is a common bacterium that can cause mild conditions such as sore throat and skin infections, but in severe cases leads to life-threatening illnesses. Thousands of people in low and middle-income countries die each year after contracting the infection, however, deaths from Strep A are relatively uncommon in more affluent nations by comparison. A deadly Strep A outbreak in the UK and Europe in late 2022 resulted in hundreds of deaths, including of many children. Working in partnership with the Medical Research Council (MRC) Unit The Gambia at London School of Hygiene and Tropical Medicine, the University of Sheffield research team tracked how children in The Gambia develop natural immunity to Strep A. Identifying antibodies linked to protection They were able to identify the specific antibodies that are linked to protection from the potentially fatal infection, according to the study published in Nature Medicine, a monthly medical journal. The researchers looked at how antibodies - our natural defence against infection - develop in people in The Gambia from birth and throughout their lives. It found that infants are born with some maternal protection against Strep A, but that quickly fades away. Young children rapidly develop antibody responses to various parts of the bacteria after exposure to Strep A. 'Identifying this key window for developing immunity is a critical discovery for future vaccine strategies,' the study said. Lead author Dr Alex Keeley, a Wellcome Clinical PhD Fellow in Global Health at the MRC Unit the Gambia and the University of Sheffield's Florey Institute of Infection, said understanding this process removes a major obstacle to vaccine development. 'For the first time in humans, we have observed how antibodies formed after vaccination could work to prevent infections,' he said. Gambian scientist Fatouamta Camara, who was part of the research, said Strep A has a 'devastating burden' on communities, both in health and socio-economic impact. 'A vaccine offers hope to break this cycle and allow children to thrive,' she said. Paving the way for life-saving vaccines The study was part of a collaboration between Sheffield's Florey Institute of Infection and the GSK Vaccine Institute for Global Health. Professor Thushan de Silva, Co-Director of the Florey Institute of Infection in Sheffield and a Principal Investigator at the MRC Unit The Gambia, who supervised the research, said: 'This study reflects the value of working across institutions to deliver high-quality, impactful research in global health.'
